Ameritas Investment Partners, Inc. Amgen Inc Transaction History

Ameritas Investment Partners, Inc.

$2.98 Billion
Q3 2024

A detailed history of Ameritas Investment Partners, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 22,555 shares of AMGN stock, worth $6.32 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

22,555

Previous 22,161 1.78%

Holding current value

$6.32 Million

Previous $6.92 Million 4.95%

% of portfolio

0.24%

Previous 0.24%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $121,895 - $132,927	394 Added 1.78%	22,555 $7.27 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $20,494 - $24,906	-78 Reduced 0.35%	22,161 $6.92 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $40,868 - $49,333	-152 Reduced 0.68%	22,239 $6.32 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $126,060 - $142,210	493 Added 2.25%	22,391 $6.45 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $653,982 - $811,936	2,991 Added 15.82%	21,898 $5.89 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $13,499 - $15,962	63 Added 0.33%	18,907 $4.2 Million
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $1.86 Million - $2.27 Million	-8,255 Reduced 30.46%	18,844 $4.56 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $124,821 - $158,600	-545 Reduced 1.97%	27,099 $7.12 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $673 - $759	3 Added 0.01%	27,644 $6.23 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $353,447 - $393,325	-1,532 Reduced 5.25%	27,641 $6.72 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $69,070 - $76,409	-315 Reduced 1.07%	29,173 $7.05 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $1,988 - $2,276	-10 Reduced 0.03%	29,488 $6.63 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $39,482 - $46,258	-186 Reduced 0.63%	29,498 $6.27 Million
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $35,270 - $39,130	-151 Reduced 0.51%	29,684 $7.24 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $104,519 - $121,800	-471 Reduced 1.55%	29,835 $7.26 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $9,520 - $11,337	44 Added 0.15%	30,306 $6.97 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $202,972 - $225,721	-865 Reduced 2.78%	30,262 $7.69 Million
Q2 2020 Aug 05, 2020	SELL	$197.81 - $242.74 $150,731 - $184,967	-762 Reduced 2.39%	31,127 $7.34 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $72,531 - $96,196	-398 Reduced 1.23%	31,889 $6.46 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $28,759 - $36,966	-152 Reduced 0.47%	32,287 $7.78 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $129,363 - $155,004	743 Added 2.34%	32,439 $6.28 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $51,843 - $60,772	311 Added 0.99%	31,696 $5.84 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $144,515 - $162,900	-799 Reduced 2.48%	31,385 $5.96 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $9,455 - $11,037	53 Added 0.16%	32,184 $6.27 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $239,950 - $270,512	-1,295 Reduced 3.87%	32,131 $6.66 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $401,508 - $450,981	-2,418 Reduced 6.75%	33,426 $6.17 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $707,200 - $826,452	-4,174 Reduced 10.43%	35,844 $6.11 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $452,188 - $505,232	-2,679 Reduced 6.27%	40,018 $6.91 Million
Q3 2017 Nov 15, 2017	SELL	$167.29 - $191.0 $33,458 - $38,200	-200 Reduced 0.47%	42,697 $7.7 Million
Q2 2017 Aug 15, 2017	BUY	N/A	42,897	42,897 $7.39 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Account

Ameritas Investment Partners, Inc. Amgen Inc Transaction History